GeneDx Holdings (WGS) Non-Current Deferred Tax Liability (2021 - 2026)
GeneDx Holdings (WGS) reported Non-Current Deferred Tax Liability of $1.4 million for Q1 2026, up 21.77% year-over-year from $1.2 million in Q1 2025, and up 85.47% quarter-over-quarter from $757000.0 in Q4 2025.
GeneDx Holdings (WGS) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $1.4 million in Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $1.4 million, up 21.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (up 21.77% YoY), and the FY2025 annual result was $757000.0, down 21.55% from the prior year.
- Non-Current Deferred Tax Liability grew to $1.4 million in Q1 2026 per WGS's latest filing, from $757000.0 in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $56.5 million in Q4 2023 and troughed at $747000.0 in Q2 2025.
- A 5-year average of $8.1 million and a median of $1.4 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
- The sharpest annual moves came in 2023 and 2024: Non-Current Deferred Tax Liability jumped 2024.03% in 2023, then plunged 98.29% in 2024.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $2.7 million in 2022, then jumped by 2024.03% to $56.5 million in 2023, then sank by 98.29% to $965000.0 in 2024, then retreated by 21.55% to $757000.0 in 2025, then jumped by 85.47% to $1.4 million in 2026.
- Business Quant data shows WGS's Non-Current Deferred Tax Liability at $1.4 million in Q1 2026, $757000.0 in Q4 2025, and $1.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | GeneDx Holdings | 1.65 Bn | 1.48 Bn | 68.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.40 Mn |
| Mar 31, 2026 | 1.40 Mn |
| Dec 31, 2025 | 757,000.00 |
| Dec 31, 2025 | 757,000.00 |
| Sep 30, 2025 | 1.03 Mn |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 747,000.00 |
| Jun 30, 2025 | 747,000.00 |
| Mar 31, 2025 | 1.15 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 965,000.00 |
| Dec 31, 2024 | 965,000.00 |
| Sep 30, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.42 Mn |
| Dec 31, 2023 | 56.48 Mn |
| Dec 31, 2023 | 56.48 Mn |